Sort
82,697 grants matching “vaccine development”
Chlamydial Immunity and Vaccine Development
$682,024Harlan D Caldwell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Antibody recognition of paramyxovirus surface proteins
$682,008Jarrod Mousa · Florida State University · R56 · FY2024 · AI
Disease Determinants of Urban Leptospirosis
$681,978Albert Icksang Ko · Yale University · U01 · FY2013 · AI
Epidemiology of Helicobacter Pylori Transmission
$681,962Julie Parsonnet · Stanford University · R01 · FY2008 · AI
Role of Regulatory T Cells in Parasitic Infections
$681,945Yasmine Belkaid · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Software for the complete characterization of antibody repertoires: from germline and mRNA sequence assembly to deep learning predictions of their protein structures and targets
$681,914Timothy J Durfee · Dnastar, Inc. · R44 · FY2024 · GM
The novel role of HLA-E restricted CD8 regulatory T cells in kidney allograft rejection
$681,826Jamil Azzi · Brigham And Women'S Hospital · R01 · FY2023 · AI
Novel Multiple-Stage Active Antimalarials
$681,816Papireddy Kancharla · Portland State University · R01 · FY2025 · AI
Gut Microbial and Metabolic Mediators of Rotavirus Vaccine Response
$681,780Pia S Pannaraj · Children'S Hospital Of Los Angeles · R01 · FY2020 · HD
Project 1 Viral Genomics: surveillance, epidemiology, host response, and viral immunogenicity
$681,761Pardis Christine Sabeti · Broad Institute, Inc. · U19 · FY2023 · AI
Host-virus interactions in hantavirus glycoprotein assembly
$681,755Kartik Chandran · Albert Einstein College Of Medicine · R56 · FY2024 · AI
Project 2
$681,696Maria Virginia Pascual · Research Inst Nationwide Children'S Hosp · U19 · FY2022 · AI
Innate Immunity and the HSV lytic/latent balance
$681,685David A. Leib · Harvard Medical School · P01 · FY2015 · AI
Conserved Element DNA Vaccine
$681,593Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Innate Immunity & Hemorrhagic Fever Viruses
$681,561Robert William Finberg · Harvard Medical School · U54 · FY2008 · AI
Interactions Of Human Immunodeficiency Virus With Receptors
$681,528Edward Berger · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Neonatal, Lactation, and Child Health Outcomes Following RSV Vaccination During Pregnancy
$681,509Kristin Palmsten · Healthpartners Institute · R01 · FY2025 · HD
Inflammation and Therapy for Respiratory Virus Infection
$681,505Helene Rosenberg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Neoantigen-specific T cell responses for Fibrolamellar Hepatocellular Carcinoma
$681,501Mark Yarchoan · Johns Hopkins University · R01 · FY2024 · CA
Second-Generation Novel Liver Stage Active Antimalarials
$681,482Jane X Kelly · Portland State University · R01 · FY2021 · AI
Systems Biology
$681,422Rafick-Pierre Sekaly · Beth Israel Deaconess Medical Center · U19 · FY2015 · AI
Broad-spectrum therapeutics against SARS-CoV-2 3CL protease
$681,379Raymond F. Schinazi · Emory University · R01 · FY2021 · AI
Anti-viral Mechanisms of Defensins
$681,373Jason G Smith · University Of Washington · R01 · FY2019 · AI
Porous silicon microparticle-based subunit vaccines for SARS-CoV-2
$681,312Tian Wang · University Of Texas Med Br Galveston · R01 · FY2025 · AI
Innate-adaptive crosstalk in protective and vaccine-induced immunity to TB
$681,243Jyothi Rengarajan · Emory University · R01 · FY2020 · AI